Journal Articles
Vaccine
Year : 2022
francis berenbaum : Connect in order to contact the contributor
https://hal.sorbonne-universite.fr/hal-03994741
Submitted on : Friday, February 17, 2023-4:17:51 PM
Last modification on : Monday, March 4, 2024-10:42:22 AM
Dates and versions
Identifiers
- HAL Id : hal-03994741 , version 1
- DOI : 10.1016/j.vaccine.2022.05.067
Cite
Paul Moss, Francis Berenbaum, Giuseppe Curigliano, Ayelet Grupper, Thomas Berg, et al.. Benefit–risk evaluation of COVID-19 vaccination in special population groups of interest. Vaccine, 2022, 40 (32), pp.4348-4360. ⟨10.1016/j.vaccine.2022.05.067⟩. ⟨hal-03994741⟩
Collections
7
View
0
Download